topotecan has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Bortner, CD; Kumar, A; Mason, RP; Motten, AG; Sinha, BK; van 't Erve, TJ | 1 |
| Chen, MZ; Hu, YB; Jin, JJ; Liu, HB; Lv, TF; Song, Y; Wan, B; Wang, XX; Xi, GM; Xu, WJ; Zhan, P; Zhang, XW; Zhu, SH | 1 |
3 other study(ies) available for topotecan and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Death; Cysteine; DNA Topoisomerases, Type I; Drug Combinations; Drug Synergism; Gene Expression; Glutathione; Humans; Hydrogen Peroxide; MCF-7 Cells; Necrosis; Oxidation-Reduction; Peroxidase; Reactive Oxygen Species; Topoisomerase I Inhibitors; Topotecan | 2017 |
Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition.
Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cytokines; Disease Models, Animal; Epithelial Cells; Inflammation; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Topotecan; Ventilator-Induced Lung Injury | 2018 |